Inactive Instrument
Asarina Pharma AB Stock
Stocks
ASAP
SE0011641794
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -31.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 71 | 2017-03-31 | |
Magnus Brisander
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul de Potocki
CHM | Chairman | 64 | 2017-12-31 |
Marianne Kock
BRD | Director/Board Member | 71 | 2017-12-31 |
| Director/Board Member | 52 | 2020-01-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -31.03% | -40.43% | - | - | 64.67K | |
| +5.04% | +3.66% | +50.62% | +103.77% | 66.93B | |
| +1.64% | -0.18% | +34.67% | +76.81% | 61.97B | |
| -3.18% | -0.78% | -14.14% | +369.82% | 28.26B | |
| -0.16% | -0.65% | +26.11% | +11.57% | 24.59B | |
| +2.20% | -4.72% | +2.19% | -13.14% | 24.3B | |
| +1.15% | -1.17% | +17.56% | -21.92% | 19.41B | |
| -7.03% | -10.19% | +161.91% | +303.00% | 16.77B | |
| -1.75% | -3.11% | -7.11% | +498.48% | 14.18B | |
| +4.96% | +4.63% | -2.75% | +864.40% | 14B | |
| Average | -2.83% | -3.28% | +29.90% | +243.64% | 30.05B | |
| Weighted average by Cap. | +1.27% | -1.95% | +32.36% | +169.92% |
Employees
6
